Mount Carmel’s heart and vascular teams have debuted several new, highly advanced surgical procedures in Central Ohio.
Dr. Tycel Phillips discusses the FDA approval of a Calquence combo in MCL, making it the first and only BTK inhibitor ...
Beyond surgical excellence, St. Elizabeth prioritizes a highly specialized and patient-focused approach to cardiac care.
Heart disease is the leading cause of death in the United States, and doctors suggest you might benefit from monitoring your ...
February is American Heart Month, the perfect time to empower yourself with the knowledge to improve your cardiovascular ...
Chiefs Hall of Honor member Art Still is a proud foot soldier in the Amyloidosis Army, a nonprofit he started hoping to ...
Bayer seeks European marketing approval for use of finerenone in adult patients with HF with a left ventricular ejection fraction (LVEF) of =40%: Berlin Tuesday, February 4, 2025, ...
Pulse Biosciences, Inc. (the "Company" or "Pulse Biosciences"), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablationtm (nanosecond PFA or nsPFAtm) technology, today ...
MIAMI - Pulse Biosciences, Inc. (NASDAQ: NASDAQ:PLSE), a bioelectric medicine company focusing on its proprietary CellFX nanosecond Pulsed Field Ablation (nsPFA) technology, has announced the ...
After atrial fibrillation, atrial flutter is the most important ... The diagnosis rested almost entirely with the 12 lead ECG, and treatment options included only the use of a digitalis compound to ...
A new study suggests that certain substances in the blood may help identify people with a type of irregular heartbeat called ...
Atrial fibrillation (AF ... Trial would be a further step toward doxapram as a possible new treatment option for AF patients. To conclude this review, there are many different options available to ...